Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Agents of Emerging Infectious Diseases
Juan P. Olano
,
David H. Walker
Pathology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
3
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Agents of Emerging Infectious Diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Emerging Infectious Diseases
100%
Infectious Diseases
100%
Emerging Infections
66%
Streptococcal Toxic Shock Syndrome
66%
Etiological Agent
66%
New Humanities
66%
United States
33%
West Nile Encephalitis
33%
West Nile Virus
33%
Protective Immunity
33%
Cryptosporidiosis
33%
New Antigens
33%
Bioterrorism Agent
33%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
33%
Vaccine Candidate
33%
Subunit Vaccine
33%
Venezuelan Hemorrhagic Fever
33%
Antibiotics
33%
Human Immunodeficiency Virus Type 1 (HIV-1)
33%
Human Infection
33%
Rickettsioses
33%
Case Fatality Rate
33%
Preclinical Testing
33%
Developed Countries
33%
Clinical Manifestations
33%
Rift Valley Fever Virus
33%
Influenza A
33%
Human Ehrlichiosis
33%
Bacterial Disease
33%
Microbes
33%
Virus Encephalitis
33%
Human Infectious Diseases
33%
Cardiopulmonary Function
33%
Nipah Virus
33%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
33%
Terrorist
33%
Helicobacter Pylori (H. pylori)
33%
Vaccine Platform
33%
Ebola Hemorrhagic Fever
33%
Marburg Hemorrhagic Fever
33%
Viral Hemorrhagic Fever
33%
Cassette
33%
New Disease
33%
Infectious Agents
33%
Transmissibility
33%
Argentine Hemorrhagic Fever
33%
Infectious Disease Control
33%
Retroviral Infection
33%
Immune Memory
33%
20th Century
33%
Smallpox Virus
33%
Order of Magnitude
33%
Human Herpesvirus 6 (HHV-6)
33%
Central Nervous System Involvement
33%
Hepatitis A
33%
Bolivian Hemorrhagic Fever
33%
Hepatitis E
33%
Prion Disease
33%
Viral Agents
33%
Enteric Infections
33%
Hepatitis B
33%
Commercial Interests
33%
Lyme Disease
33%
Allergy Disease
33%
Shiga Toxin
33%
HHV-8
33%
Lassa Hemorrhagic Fever
33%
Disease Agent
33%
Acute Respiratory Infection
33%
Bartonellosis
33%
HTLV-II
33%
Legionnaires' Disease
33%
Socio-economic Change
33%
Human Herpesvirus
33%
H5N1 Influenza
33%
Nuclear War
33%
HHV-7
33%
Veterinary Diseases
33%
Vaccine Response
33%
FDA Approval
33%
Public Health Campaigns
33%
Ehrlichiosis
33%
Gastric Disease
33%
Nuclear Attack
33%
Duodenal Diseases
33%
Medicine and Dentistry
Infection
100%
Emerging Infectious Disease
100%
Infectious Disease
100%
Antigen
50%
Public Health
25%
Cryptosporidiosis
25%
Venezuelan Hemorrhagic Fever
25%
Central Nervous System
25%
West Nile Virus
25%
Human Granulocytic Anaplasmosis
25%
Bacterial Disease
25%
SARS Coronavirus
25%
Case Fatality Rate
25%
Severe Acute Respiratory Syndrome
25%
Nipah Virus Infection
25%
Stomach Disease
25%
Helicobacter Pylori
25%
Respiratory Tract Infection
25%
Retrovirus Infection
25%
Rift Valley Fever Virus
25%
Encephalitis
25%
Herpesviridae
25%
Smallpox Virus
25%
Ehrlichiosis
25%
Viral Hemorrhagic Fever
25%
Human Immunodeficiency Virus 1
25%
Systemic Disease
25%
Subunit Vaccine
25%
Ebola Hemorrhagic Fever
25%
Marburg Hemorrhagic Fever
25%
Hepatitis B
25%
Argentine Hemorrhagic Fever
25%
Human T-Lymphotropic Virus 1
25%
Hepatitis A
25%
Bolivian Hemorrhagic Fever
25%
Toxic Shock Syndrome
25%
Pontiac Fever
25%
Bartonellosis
25%
Intestine Infection
25%
Influenza A (H5N1)
25%
Shiga Toxin
25%
Human T-Lymphotropic Virus 2
25%
Hepatitis E
25%
Duodenum Disease
25%
Immunological Memory
25%
Antibiotics
25%
Diseases
25%
Lyme Disease
25%
Prion Disease
25%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Infection
62%
Antigen
25%
Syndrome
12%
Infectious Agent
12%
Antibiotics
12%
Subunit Vaccine
12%
Virus Hemorrhagic Fever
12%
Rift Valley Fever Virus
12%
Encephalitis
12%
West Nile Virus
12%
Nipah Virus Infection
12%
Severe Acute Respiratory Syndrome
12%
Case Fatality Rate
12%
Helicobacter Pylori
12%
Respiratory Tract Infection
12%
Argentine Hemorrhagic Fever
12%
SARS Coronavirus
12%
Smallpox Virus
12%
Stomach Disorders
12%
Cryptosporidiosis
12%
Hepatitis B
12%
Ebola Hemorrhagic Fever
12%
Marburg Virus Disease
12%
Hepatitis A
12%
Venezuelan Hemorrhagic Fever
12%
Human Granulocytic Anaplasmosis
12%
Ehrlichiosis
12%
Systemic Disease
12%
Human Immunodeficiency Virus 1
12%
Lyme Disease
12%
Herpesviridae
12%
Shiga Toxin
12%
Bartonellosis
12%
Toxic Shock Syndrome
12%
Intestine Infection
12%
Hepatitis E
12%
Human T-Lymphotropic Virus 1
12%
Prion Protein
12%
Influenza A (H5N1)
12%
Bolivian Hemorrhagic Fever
12%
Human T-Lymphotropic Virus 2
12%
Legionnaire Disease
12%
Duodenum Disease
12%
Retrovirus Infection
12%
Microorganism
12%
Veterinary Science and Veterinary Medicine
Infectious Disease
100%
Emerging Infectious Disease
100%
Diseases
71%
Infectious Disease
57%
Hemorrhagic Fever
28%
SARS Coronavirus
14%
Severe Acute Respiratory Syndrome
14%
Rift Valley Fever
14%
West Nile Virus
14%
Hepatitis A
14%
Central Nervous System
14%
Herpesviridae
14%
Hepatitis B
14%
Hepatitis E
14%
Lyme Disease
14%
Influenza
14%
Encephalitis
14%
Ehrlichiosis
14%
Human Granulocytic Anaplasmosis
14%
Viral Encephalitis
14%
Smallpox
14%
Helicobacter pylori
14%
Public Health
14%
Acute Respiratory Infection
14%
Toxic Shock Syndrome
14%
Legionnaires' Disease
14%